Detalhe da pesquisa
1.
Characterization of three novel pathogenic SLC40A1 mutations and genotype/phenotype correlations in 7 Italian families with type 4 hereditary hemochromatosis.
Biochim Biophys Acta Mol Basis Dis
; 1864(2): 464-470, 2018 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-29154924
2.
Chelation efficacy and erythroid response during deferasirox treatment in patients with myeloproliferative neoplasms in fibrotic phase.
Eur J Haematol
; 96(6): 643-9, 2016 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-26277477
3.
Spleen enlargement is a risk factor for thrombosis in essential thrombocythemia: Evaluation on 1,297 patients.
Am J Hematol
; 91(3): 318-21, 2016 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-26748894
4.
Thrombosis and survival in essential thrombocythemia: a regional study of 1,144 patients.
Am J Hematol
; 89(5): 542-6, 2014 May.
Artigo
Inglês
| MEDLINE | ID: mdl-24481665
5.
Impact on mental health, disease management, and socioeconomic modifications in hematological patients during the COVID-19 pandemic in Italy.
Ther Adv Hematol
; 14: 20406207231190683, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37693118
6.
Symptomatic mucocutaneous toxicity of hydroxyurea in Philadelphia chromosome-negative myeloproliferative neoplasms: the Mister Hyde face of a safe drug.
Cancer
; 118(2): 404-9, 2012 Jan 15.
Artigo
Inglês
| MEDLINE | ID: mdl-21692060
7.
Long-term safety and efficacy of givinostat in polycythemia vera: 4-year mean follow up of three phase 1/2 studies and a compassionate use program.
Blood Cancer J
; 11(3): 53, 2021 03 06.
Artigo
Inglês
| MEDLINE | ID: mdl-33677466
8.
Deferasirox in the treatment of iron overload during myeloproliferative neoplasms in fibrotic phase: does ferritin decrement matter?
Leuk Res
; 76: 65-69, 2019 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30578958
9.
Sequential occurrence of chronic myeloproliferative and lymphoproliferative neoplasms: a collaborative retrospective study by pH-negative MPN latial group.
Leuk Lymphoma
; 63(11): 2751-2753, 2022 11.
Artigo
Inglês
| MEDLINE | ID: mdl-35758305
10.
Role of treatment on the development of secondary malignancies in patients with essential thrombocythemia.
Cancer Med
; 6(6): 1233-1239, 2017 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-28544749
11.
High platelet count at diagnosis is a protective factor for thrombosis in patients with essential thrombocythemia.
Thromb Res
; 156: 168-171, 2017 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-28662484
12.
Safety and efficacy of the maximum tolerated dose of givinostat in polycythemia vera: a two-part Phase Ib/II study.
Leukemia
; 34(8): 2234-2237, 2020 08.
Artigo
Inglês
| MEDLINE | ID: mdl-32047238
13.
Extramedullary liver plasmacytoma a rare presentation.
Leuk Lymphoma
; 44(6): 1075-6, 2003 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-12854914
14.
Prognostic factors for thrombosis-free survival and overall survival in polycythemia vera: A retrospective analysis of 623 PTS With long follow-up.
Leuk Res
; 69: 18-23, 2018 06.
Artigo
Inglês
| MEDLINE | ID: mdl-29625320
15.
Lenalidomide can induce long-term responses in patients with multiple myeloma relapsing after multiple chemotherapy lines, in particular after allogeneic transplant.
Leuk Lymphoma
; 52(7): 1262-70, 2011 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-21534872
16.
Proposal and validation of prognostic scoring systems for IgG and IgA monoclonal gammopathies of undetermined significance.
Clin Cancer Res
; 15(13): 4439-45, 2009 Jul 01.
Artigo
Inglês
| MEDLINE | ID: mdl-19509142